A team of scientists, led by Paul S. Mischel, MD, a member of the Ludwig Institute for Cancer Research and professor in the Department of Pathology at the University of California, San Diego School of Medicine, has found that brain cancer cells resist therapy by dialing down the gene mutation targeted by drugs, then re-amplify that growth-promoting mutation after therapy has stopped.
When former foster youth join the UC San Diego community as undergraduates, they are immediately embraced by a close-knit extended family of caring staff members who affirm the students’ potential and assure comprehensive support.
GiveDirectly.org sends cash to poor people – with no strings attached. The nonprofit was co-founded by UC San Diego development economist Paul Niehaus. Called “crazy” by many, Niehaus and his colleagues are being honored by Foreign Policy magazine as “Leading Global Thinkers” of 2013. And a top charity evaluator has just rated GiveDirectly as its No. 1.
Over the past seven years, more than 7,000 sixth graders from 26 schools in San Diego County have visited the Jacobs School of Engineering to build model structures and test them on small shake tables. It’s all part of the Earthquake Engineering with K’NEX Outreach Program run by the UC San Diego chapter of the Society of Civil and Structural Engineers.
A team of UC San Diego biophysicists used quantitative models of bacterial growth to discover the bizarre way by which antibiotic resistance allows bacteria to multiply in the presence of antibiotics, a growing health problem in hospitals and nursing homes across the United States.
Expanding their efforts to keep citizens safe on San Diego roadways, UC San Diego’s Training, Research and Education for Driving Safety (TREDS) program announced today that they are launching a new distracted driving education project called Just Drive - Take Action Against Distraction, a one hour class free of charge offered to businesses in San Diego.
Nanosponges that soak up a dangerous pore-forming toxin produced by MRSA (methicillin-resistant Staphylococcus aureus) could serve as a safe and effective vaccine against this toxin. This “nanosponge vaccine” enabled the immune systems of mice to block the adverse effects of the alpha-haemolysin toxin from MRSA—both within the bloodstream and on the skin. Nanoengineers from the University of California, San Diego described the safety and efficacy of this nanosponge vaccine in the December 1 issue of Nature Nanotechnology.
Using advanced methodologies that pit drug compounds against specific types of malaria parasite cells, an international team of scientists, including researchers at the University of California, San Diego School of Medicine and the Genomics Institute of the Novartis Research Foundation, have identified a potential new weapon and approach for attacking the parasites that cause malaria.
Six professors at the University of California, San Diego have been named 2013 Fellows of the American Association for the Advancement of Science, the nation’s largest general science organization.
Much more than financial advisors, UC San Diego Foundation trustees work as a team to connect the university with community partners and discover resources needed to launch innovative programs. Some of the campus’s most impactful initiatives—such as the Qualcomm Institute, the Preuss School UCSD, Moores Cancer Center, and more—were made possible through gifts to the Foundation. To ensure the continued success and growth of the campus, seven new trustees will join the 2013-14 Foundation board, including two UC San Diego alumni, a former chancellor and several regional business executives.